质子微束放疗诱导大鼠原位胶质母细胞瘤代谢与突触重塑
研究在大鼠原位胶质母细胞瘤模型中比较质子微束放疗(pMBRT)与常规质子治疗,照射后7天进行蛋白质组学与免疫荧光分析。结果显示两种方式均抑制肿瘤增殖信号,但pMBRT伴随独特的肿瘤代谢调节及正常脑组织突触相关蛋白表达的保留,提示其兼具肿瘤增敏与正常组织保护的双重潜力。
要点
- pMBRT在胶质母细胞瘤大鼠模型中诱导独特的肿瘤代谢调节,可能反映放射敏感性增加。
- pMBRT在正常脑组织中保留突触相关蛋白表达并调节氮代谢。
- pMBRT具有肿瘤增敏与正常脑组织保护的双重能力,支持其转化潜力。
核心结论
- pMBRT具有使肿瘤对放射增敏同时保护健康脑组织的双重能力,支持其用于胶质母细胞瘤治疗的转化潜力。
研究设计与样本
- 研究将雄性Fischer大鼠右侧尾状核原位注射50,000个RG2细胞,第13天经生物发光验证肿瘤摄取后,第14天接受pMBRT或常规质子治疗。
- 照射后7天取脑组织进行非靶向蛋白质组学分析与免疫荧光染色,比较pMBRT与常规质子治疗的放射生物学机制。
主要发现
- 照射后7天,两种方式均减弱肿瘤增殖信号。
- pMBRT与肿瘤独特的代谢调节相关, notably vanin-1上调与谷氨酰胺合成酶诱导减弱,这些变化可能反映肿瘤放射敏感性增加,并经脑冷冻切片免疫荧光验证。
- 在正常脑组织中,pMBRT与突触相关蛋白表达的保留及氮代谢调节相关,包括谷氨酸脱氢酶水平改变。
临床怎么用
- 临床可关注pMBRT在胶质母细胞瘤中同时实现肿瘤增敏与正常脑组织保护的双重潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GB) is an aggressive primary brain tumor with limited therapeutic options. Although radiation therapy (RT) remains a cornerstone of treatment, its efficacy is constrained by collateral damage to healthy brain tissue. Proton minibeam RT (pMBRT), a spatially fractionated modality, has shown promise in preclinical models and early clinical applications by mitigating normal tissue toxicity while enhancing tumor control. Notably, previous studies in rats have reported long-term neuroprotective effects after brain irradiation, as well as the emergence of long-term survivors accompanied by immune memory in GB-bearing models. To investigate the underlying radiobiological mechanisms of pMBRT, we performed an untargeted proteomics profiling comparing pMBRT with conventional proton therapy in an orthotopic rat model of GB. METHODS AND MATERIALS: Male Fischer rats were orthotopically injected with 50,000 RG2 cells into the right caudate nucleus. After validation of tumor uptake at day 13 by bioluminescence, rats received pMBRT or conventional proton therapy treatment at day 14. Seven days after irradiation, brains were harvested to perform proteomics analysis and immunofluorescence staining. RESULTS: Both modalities attenuated proliferative signaling in tumors after 7 days; however, pMBRT was associated with distinct metabolic modulation in tumors, notably upregulation of vanin-1 and attenuated glutamine synthetase induction, changes that may reflect increased tumor radiosensitivity. These alterations were further validated via immunofluorescence on brain cryosections. In normal brain, pMBRT was associated with preservation of synaptic-related protein expression and modulation of nitrogen metabolism, including altered glutamate dehydrogenase levels. CONCLUSIONS: Collectively, these findings highlight the dual capacity of pMBRT to sensitize tumors to radiation while preserving healthy brain tissue, supporting its translational potential for GB treatment.
引用
- Roncali L, Riquelme-Perez M, Teles RHG, et al. Proton Minibeam Radiation Therapy Induces Distinct Metabolic and Synaptic Remodeling in Rats With Orthotopic Glioblastoma. Int J Radiat Oncol Biol Phys. 2026. PMID: 42648577. doi:10.1016/j.ijrobp.2026.08.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。